A new flu treatment could drastically reduce one of flu's deadliest complications—bacterial pneumonia—by helping the lungs ...
Backed by Novo Holdings and multiple other prominent investors, the biotech is developing what it’s positioning as superior ...
Avalyn Pharma is eyeing an IPO as the biotech seeks more funds to take its inhaled versions of approved drugs for lung ...
The FDA has approved Cipla's nintedanib capsules as a new generic version of Ofev for treating idiopathic pulmonary fibrosis ...
In a preclinical study published today in Cancer Research, a journal of the American Association for Cancer Research, ...
It’s been a little over two months since President Donald Trump’s direct-to-consumer pharmaceutical site, TrumpRx, launched, ...
Scientists have created a new "molecular map" uncovering how an important human receptor involved in blood clotting and ...
GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick ...
When shopping for allergy medications, skip diphenhydramine and phenylephrine in the pharmacy aisle and opt for nasal steroids, second-generation antihistamines, and normal saline instead.
Just think, we may have never gotten the “Oh, oh, oh, Ozempic!” jingle stuck in our heads if it wasn’t for a creepy, ...
Pegvisomant, developed by professor John Kopchick in 1987, shows potential to make treatment-resistant lung cancer cells more ...
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Stay confident in today’s economy with useful tips and enter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results